Once-daily dose regimen of ribavirin is interchangeable with a twice-daily dose regimen: randomized open clinical trial

BACKGROUND: The combination of ribavirin (RBV) and pegylated interferon (PEG-IFN) is effective in the treatment of chronic hepatitis C infection. Reducing the frequency of RBV intake from twice to once a day will improve compliance and opens up the opportunity to combine RBV with new and more specif...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmgenomics Pers Med
Main Authors: Balk, Jiska M, Haenen, Guido RMM, Koc, Özgür M, Peters, Ron, Bast, Aalt, van der Vijgh, Wim JF, Koek, Ger H
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4593207/
https://ncbi.nlm.nih.gov/pubmed/26445557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PGPM.S82782
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki